November 20, 2017

November 20, 2017

Subscribe to Latest Legal News and Analysis

November 17, 2017

Subscribe to Latest Legal News and Analysis

Sightpath Medical Pays $12 Million to Settle Allegations of False Claims Act Violations and Medicare Fraud

On August 21, 2017, Acting United States Attorney Gregory G. Brooker of the United States Attorney’s Office for the District of Minnesota announced that the U.S. government reached a settlement of $12 million with Sightpath Medical over its alleged use of kickbacks to promote its products, in violation of federal law. Whistleblower Kipp Fesenmaier, former vice president of the medical devices and services company, brought the qui tam lawsuit against the company in 2013 for allegedly violating the False Claims Act and the Anti-Kickback Statute. Fesenmaier claimed that Sightpath knowingly took advantage of Medicare by using extravagant trips and social events to entice doctors to use its products and services, which were then billed to government healthcare programs. The settlement is resolved with no admissions of liability or wrongdoing by the defendants, although their agreement to pay $12 million is a strong indication that the whistleblower’s allegations had strong support in the evidence.

Sightpath Medical is a subsidiary of TLC Vision Corporation, a privately-held Canadian company and provider of the popular Lasik eye correction procedure. Sightpath specializes in products and services in eye surgery centers and doctors’ offices across Canada and the U.S. that offer services that can be paid for by federal healthcare programs, such as Medicare. The lawsuit claimed that between January 1, 2006 and January 1, 2015, Sightpath Medical planned luxury hunting, skiing, fishing, and golfing trips, and offered phantom “consulting” agreements, as a way to bribe physicians to use its products in their practice, including the mobile cataract surgery equipment and eye surgery procedures that would be covered by Medicare. By improperly inducing these doctors to use its products and services, Sightpath violated the Anti-Kickback Statute and the False Claims Act. Former Sightpath president James Tiffany was also a defendant in the lawsuit, and also a party to the the $12 million settlement with whistleblower Fesenmaier and the U.S. government.

FBI Special Agent in Charge Richard T. Thornton of the Minneapolis Division stated, “The FBI together with our law enforcement partners aggressively investigate companies and individuals who engage in kickback schemes at the expense of Medicare and other federal health care programs.” Adding that, “Those who seek to exploit the nation’s healthcare system through fraud will be held accountable.”

As a whistleblower protected under the False Claims Act, Mr. Fesenmaier is entitled to receive between 15 and 30 percent of the $12 million recovered by his successful qui tam lawsuit. The settlement of this case stipulates that he will receive 19.5% of the amount recovered.  This means that, as the qui tam whistleblower, Mr. Fesenmaier will receive approximately $2.3 million as his reward for bringing the lawsuit.

Healthcare companies like Sightpath Medical often engage in government programs fraud by using kickback schemes, or by submitting false claims to Medicare and Medicaid. 

© 2017 by Tycko & Zavareei LLP

TRENDING LEGAL ANALYSIS


About this Author

Jonathan K. Tycko leads the Whistleblower Practice Group of Tycko & Zavareei LLP

In recent years, the laws of the United States have undergone a whistleblower revolution. Federal and state governments now offer substantial monetary awards to individuals who come forward with information about fraud on government programs, tax fraud, securities fraud, and fraud involving the banking industry. Whistleblowers also now have important legal protections, designed to prevent retaliation and blacklisting.

The law firm of Tycko & Zavareei LLP works on the cutting edge of this whistleblower revolution, taking on even the most complex and confidential whistleblower...

202-973-0900